DA Davidson Reiterates Buy Rating on Diebold Nixdorf (DBD) Ahead of Q1 Results

DA Davidson analyst Matthew Summerville reiterated a Buy rating and $100.00 price target on Diebold Nixdorf (NYSE: DBD).

The analyst commented, "Following an additional review of commentary regarding Services margin and overall EBITDA cadence for DBD, we made a few minor, surgical adjustments to our quarterly assumptions. While these changes were very minor, we point out that our full-year estimates remained completely unchanged in terms of revenue, adjusted EBITDA, and EPS. We presently rate DBD shares BUY with a $100 PT, which we plan to review following the company’s upcoming 1Q26 earnings release and conference call scheduled April 30th before the market open."

For an analyst ratings summary and ratings history on Diebold Nixdorf click here. For more ratings news on Diebold Nixdorf click here.

Shares of Diebold Nixdorf closed at $87.54 yesterday.

You May Also Be Interested In

• Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised
• Cantor Fitzgerald Starts Factorial Energy (FAC) at Overweight
• Abbvie (ABBV) PT Raised to $273 at Canaccord